The 6 analysts offering 12-month price forecasts for Adaptive Biotechnologies Corp have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 6.00. The median estimate represents a +127.79% increase from the last price of 4.39.
The current consensus among 8 polled investment analysts is to Buy stock in Adaptive Biotechnologies Corp. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.20
Reporting Date Feb 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.